loading

Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
26.89%
2.3398
3.2003 3.2257 2.8837 3.2036
Operating Income/Loss
26.89%
-2.3398
-3.2003 -3.2257 -2.8837 -3.2036
Income/Loss From Continuing Operations Before Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Income/Loss From Continuing Operations After Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Net Income/Loss
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 3.1343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.1547
- - - -
Diluted Average Shares
5.1547
- - - -
Basic Earnings Per Share
-0.45
- - - -
Diluted Earnings Per Share
-0.45
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):